
Harvard Bioscience HBIO
Quarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience ROCE Ratio 2011-2026 | HBIO
Annual ROCE Ratio Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -353.72 | -9.81 | 2.59 | -9.6 | 2.48 | 0.16 | 1.32 | 0.67 | -0.11 | -1.22 | -0.92 | 5.8 | 3.09 | 2.81 | 5.59 | 11.32 | 10.7 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.32 | -353.72 | -19.34 |
Quarterly ROCE Ratio Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -350.29 | -341.48 | -345.95 | -344.06 | -9.26 | -10.51 | -6.59 | -1.16 | 2.15 | -3.07 | 3.34 | -6.5 | -8.86 | -8.14 | -2.84 | -8.31 | 0.48 | 0.71 | 0.73 | -3.62 | -3.31 | -1.31 | -3.22 | -3.66 | 0.46 | 0.57 | 3.31 | 2.57 | 1.19 | -0.45 | -2.01 | -1.88 | -0.78 | -2.8 | -3.45 | -4.28 | -4.15 | -2.45 | -2.32 | -1.03 | -2.21 | -0.13 | 2.36 | 4.05 | 7.36 | 4.13 | 3.07 | 1.96 | 1.55 | 4.6 | 5.27 | 6.94 | 7.51 | 6.92 | 6.04 | 6.3 | 1.45 | 0.23 | 2.64 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.51 | -350.29 | -23.77 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
8.29 | $ 62.02 | 2.78 % | $ 12.3 B | ||
|
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | ||
|
Glaukos Corporation
GKOS
|
-30.42 | $ 121.69 | 7.24 % | $ 6.96 B | ||
|
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
16.53 | $ 418.82 | 2.83 % | $ 149 B | ||
|
Alcon
ALC
|
-2.56 | $ 66.58 | 3.67 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
2.02 | $ 134.93 | 3.38 % | $ 3.32 B | ||
|
Repro Med Systems
KRMD
|
-17.44 | $ 4.14 | 5.61 % | $ 191 M | ||
|
iRhythm Technologies
IRTC
|
-37.58 | $ 107.35 | 2.67 % | $ 3.44 B | ||
|
LeMaitre Vascular
LMAT
|
17.26 | - | - | $ 2.12 B | ||
|
Masimo Corporation
MASI
|
-25.35 | $ 178.9 | 0.07 % | $ 9.54 B | ||
|
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | ||
|
Microbot Medical
MBOT
|
-19.01 | - | - | $ 89.7 M | ||
|
Ekso Bionics Holdings
EKSO
|
-147.62 | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
-202.54 | $ 0.43 | 11.28 % | $ 35.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
769.63 | $ 9.94 | 0.81 % | $ 84.3 K | ||
|
Envista Holdings Corporation
NVST
|
6.96 | $ 22.87 | 2.1 % | $ 3.84 B | ||
|
Haemonetics Corporation
HAE
|
19.68 | $ 69.85 | 6.03 % | $ 3.3 B | ||
|
Isoray
ISR
|
-54.85 | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
15.34 | $ 212.24 | 0.98 % | $ 20.8 B | ||
|
STAAR Surgical Company
STAA
|
-26.65 | $ 29.86 | 5.66 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
20.79 | $ 9.12 | 1.0 % | $ 188 M | ||
|
Teleflex Incorporated
TFX
|
0.44 | $ 132.11 | 2.76 % | $ 5.9 B | ||
|
Merit Medical Systems
MMSI
|
11.66 | $ 63.04 | 3.94 % | $ 3.73 B | ||
|
Utah Medical Products
UTMD
|
9.56 | $ 67.99 | 3.75 % | $ 220 M | ||
|
West Pharmaceutical Services
WST
|
18.42 | $ 317.32 | 0.32 % | $ 22.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
-31.52 | $ 9.88 | 2.49 % | $ 1.97 B | ||
|
Pulse Biosciences
PLSE
|
-95.39 | $ 26.94 | 7.8 % | $ 1.82 B | ||
|
Retractable Technologies
RVP
|
-28.47 | $ 0.66 | 0.41 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
22.96 | $ 67.0 | 2.81 % | $ 220 M | ||
|
Predictive Oncology
POAI
|
-379.14 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
-4.46 | - | - | $ 1.29 B | ||
|
Stereotaxis
STXS
|
-164.02 | $ 1.88 | 2.17 % | $ 171 M | ||
|
Baxter International
BAX
|
-5.03 | $ 19.35 | 4.31 % | $ 9.93 B | ||
|
ResMed
RMD
|
22.7 | $ 194.32 | 4.2 % | $ 28.4 B | ||
|
AtriCure
ATRC
|
-1.92 | - | - | $ 1.3 B | ||
|
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-21.84 | $ 12.03 | 7.41 % | $ 491 M | ||
|
Becton, Dickinson and Company
BDX
|
10.16 | $ 149.56 | 2.73 % | $ 43 B | ||
|
Nephros
NEPH
|
11.23 | $ 3.59 | -1.37 % | $ 38.1 M | ||
|
OraSure Technologies
OSUR
|
-19.81 | $ 4.17 | 5.57 % | $ 306 M | ||
|
Repligen Corporation
RGEN
|
1.96 | $ 126.55 | 3.96 % | $ 7.12 M |